High-Risk Localized and Locally Advanced Prostate Cancer
Kouji Izumi$62.17
$73.14
Around 20%-30% of nonmetastatic prostate cancer patients have high-risk localized disease. The best treatment for high-risk localized disease is still unclear, and the reliability of the definition of "high-risk" may need to be validated first. Although recent advances in radiotherapy for prostate cancer have yielded excellent long-term results, even in high-risk localized disease, there are no studies directly comparing it with local treatment options, such as prostatectomy. To address current challenges in high-risk localized and locally advanced prostate cancer, 12 original and 3 review articles covering aspects from basic research to clinical trials are published in this Special Issue.
Binding Type: Hardcover
Publisher: Mdpi AG
Published: 07/14/2023
ISBN: 9783036581682
Pages: 244
Weight: 1.60lbs
Size: 9.61h x 6.69w x 0.81d